DOI: https://doi.org/10.14710/dmj.v12i3.37292

Post COVID-19 Immunization Herpes Zoster Reactivation In Asia : A Literature Review

*Nurul Nisa Ulfa  -  Faculty of medecine, Diponegoro University, Indonesia, Indonesia
Danisa Diandra Safarina  -  Faculty of Medicine, Diponegoro University, Indonesia, Indonesia
Puguh Riyanto  -  Department of Dermatovenereology, Faculty of Medicine, Diponegoro University, Indonesia, Indonesia

Citation Format:
Abstract

Background: The COVID-19 vaccine that targets viral mRNA has been created and can be used as an effort to end the COVID-19 pandemic that has hit the world since 2020. The COVID-19 vaccine currently being developed has proven its effectiveness and safety in the general adult population.

Objective: To identify reactivation of Herpes Zoster virus post COVID-19 vaccine.

Methods: This article review discusses four case reports of Herpes Zoster following the COVID-19 immunization in Asia which were obtained from various sources such as Pubmed Medline Embase.

Results: The mRNA-type vaccine is associated with skin manifestations with an increased incidence (14.4%) of Herpes Zoster which was observed around 6-8 days after administration of the first dose of vaccine (BNT162b2 vaccine) and 1.5% after administration of the mRNA- 1273 which occurred in the Asian Oceanian race. COVID-19 vaccine substances such as polyethylene glycol (PEG), the polysorbate present in mRNA vaccines, and polysorbate 80 are suspected causing an allergic reactions.

Conclusion: Health workers must be careful in administering the COVID-19 vaccine, especially to individuals who have risk factors that can decrease their immune system so it can cause reactivation of Herpes Zoster.

 

 

 

Fulltext View|Download
Keywords: Covid-19; Herpes Zoster;Covid-19 Vaccine;Reactivation of Herpes Zoster Virus Post Covid-19 Vaccine

Article Metrics:

Article Info
Section: Original Articles
Language : EN
Recent articles
Anatomy Practice during COVID-19 Pandemic THE RELATIONSHIP OF PERSONAL HYGIENE ON THE SEVERITY OF ACNE VULGARIS IN MEDICAL STUDENTS WAHID HASYIM UNIVERSITY Correlation between Maternal Characteristics and The Incidence of COVID-19 in Pregnant Woman: A Cross-Sectional Study CASE REPORT : FISH BONE CORPAL IN ESOPHAGUS CASE REPORT : A 30-YEAR-OLD FEMALE IN THIRD TRIMESTER PREGNANCY WITH VARICELLA CASE REPORT DIAGNOSIS AND TREATMENT OF VERNAL KERATOCONJUNCTIVITIS More recent articles
  1. Shereen MA, Khan S, Kazmi A, Bashir N, R. S. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. 2020;24:91-8. DOI: 10.1016/j.jare.2020.03.005
  2. CSIS. National Responses to COVID-19 in Southeast Asia. Washington DC: 2022
  3. Barouch DH. Covid-19 Vaccines — Immunity, Variants, Boosters. N Engl J Med. 2022;378(11):1011-20. Available from: https://www.nejm.org/doi/full/10.56/NEJMra2206573
  4. Watson OJ, Barnsley G, Toor J, Hogan AB, Winskill P, Ghani AC. Global impact of the first year of COVID-19 vaccination: a mathematical modelling study. Lancet Infect Dis [Internet]. 2022;22(9):1293-302
  5. WHO. Side Effects of COVID-19 Vaccines [Internet]. 2021. Available from: https://www.who.int/news-room/feature-stories/detail/side-effects-of-covid-19-vaccines
  6. Eden David BA ALM. Herpes Zoster Following COVID-19 Vaccination. J Drugs Dermatology [Internet]. 2021;20(8): . Available from: https://jddonline.com/articles/herpes-zoster-following-covid-19-vaccination-S1545961621P0898X/
  7. Shengli Xia KD. Effect Of An Inactivated Vaccine Against SARS-COV-2 On Safety and Immunogenicity Outcomes. 2020;324(10):1-10
  8. Lotfi M, Hamblin MR, N. R. The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information. Clin Chim Acta [Internet]. 2020;508((January)):254-66. Available from: www.elsevier.com/locate/cca Review
  9. Préta LH, Contejean A, Salvo F, Treluyer JM, Charlier C, Chouchana L. Association study between herpes zoster reporting and mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273). Br J Clin Pharmacol [Internet]. 2022;88(7):3529-34. Available from: https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.15280
  10. You I-C, Ahn M, Cho N-C. A Case Report of Herpes Zoster Opthalmicus and Meningitis After COVID-19 Vaccination. J Korean Med Sci [Internet]. 2022;37. Available from: https://jkms.org/pdf/10.3346/jkms.2022.37.e165
  11. Shah S, Baral B, Chamlagain R, Murarka H, Raj Adhikari Y, B. SP. Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal. Clin Case Reports [Internet]. 2021;9(12):1-3. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650754/pdf/CCR3-9-e05188.pdf
  12. BM Munasinghe, UPM Fernando, DS. MM. Reactivation of Varicella-Zoster Virus Following MRNA COVID-19 Vaccination In A Patient With Moderately Differentiated Adenocarcinoma Of Rectum : A Case Report. 2022;10:1-4. Available from: https://pdfs.semanticscholar.org/5c4f/680a62932bcde4e4c3df17e16d7eb710de.pdf?_ga=2.264491148.2079252552.1667980922-876371522
  13. Aksu, Saliha Busra GZO. A Rare Case of Shingles After COVID-19 Vaccine: Is It a Possible Adverse Effect? Clin Exp Vaccine Res. 2021
  14. Nawaf Almutairi, Abdulrahman N, SA. MA. Herpes zoster in The Era of COVID 19: A Prospective Observational Study to Probe The Association of Herpes Zoster with COVID 19 Infection and Vaccination. 2022
  15. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M ea. Recommendations for the management of herpes zoster. Clin Infect Dis [Internet]. 2007;44(1):1-26. Available from: https://academic.oup.com/cid/article/44/Supplement_1/S1/334966?login=true
  16. McMahon DE AE, Rosenbach M, Lipoff JB, Moustafa D, Tyagi A, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46-55
  17. West JA GS, Damania B. Toll-like receptor sensing of human herpesvirus infection. Front Cell Infect Microbiol [Internet]. 2012;2(October):122. Available from: https://www.frontiersin.org/articles/10.3389/fcimb.2012.00122/full
  18. Anderson EJ RN, Widge AT, Jackson LA, Roberts PC, Makhene M, et al. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med [Internet]. 2020;383(25):2427-38. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556339/pdf/NEJMoa2028436.pdf
  19. Psichogiou M KA, Poulakou G, Antoniadou A, Kotanidou A, Degiannis D, et al. . Comparative immunogenicity of BNT162b2 mRNA vaccine with natural SARS-CoV-2 infection. Vaccines [Internet]. 2021;9(9):1-13. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556339/pdf/NEJMoa2028436.pdf
  20. Psichogiou M SM, Mikos N, Hatzakis A. Reactivation of varicella zoster virus after vaccination for sars-cov-2. Vaccines. 2021;9(6):1-8
  21. WHO. The COVID-19 Vaccine Tracker and Landscape Compiles Detailed Information Of Each COVID-19 Vaccine Candidate In Development By Closely Monitoring Their Progress Through The Pipeline. 2022. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
  22. Lucie Renoud CK, Pharm BR. Association of Facial Paralysis With mRNA COVID-19 Vaccines. 2021;181(9):1243-5. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080152/
  23. Bogdanov G BI, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines: Effects of COVID-19 vaccines. Clin Dermatol [Internet]. 2021;39(3):523-32. Available from: https://doi.org/10.1016/j.clindermatol.2021.04.001
  24. G.Kounis N, Loanna Koniari C de G. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes. Vaccines. 2021;9(3)
  25. Shauna M Rice SDFN. The Art of Prevention: COVID-19 Vaccine Preparedness For the Dermatologist. Dermatology. 2021;7(2)

Last update:

No citation recorded.

Last update:

No citation recorded.